Holocene Advisors’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-56,610
Closed -$639K 824
2025
Q4
$639K Sell
56,610
-709,264
-93% -$8.79M ﹤0.01% 649
2025
Q3
$11.5M Sell
765,874
-729,767
-49% -$10.6M 0.03% 287
2025
Q2
$21.1M Buy
1,495,641
+239,889
+19% +$4.28M 0.05% 233
2025
Q1
$30.2M Buy
1,255,752
+166,910
+15% +$5.89M 0.09% 211
2024
Q4
$40.7M Buy
1,088,842
+236,215
+28% +$11M 0.13% 188
2024
Q3
$42.6M Sell
852,627
-843,728
-50% -$32.8M 0.17% 169
2024
Q2
$58.9M Buy
1,696,355
+323,629
+24% +$12.8M 0.25% 123
2024
Q1
$75.1M Sell
1,372,726
-68,635
-5% -$3.4M 0.28% 116
2023
Q4
$61.7M Sell
1,441,361
-528,391
-27% -$16.4M 0.24% 131
2023
Q3
$51.2M Sell
1,969,752
-94,236
-5% -$1.96M 0.22% 138
2023
Q2
$49.4M Buy
2,063,988
+20,279
+1% +$349K 0.21% 137
2023
Q1
$27.9M Buy
2,043,709
+338,429
+20% +$5.39M 0.14% 177
2022
Q4
$23.7M Buy
+1,705,280
New +$24.1M 0.14% 164

Other funds holding BHVN

Holocene Advisors's BHVN Position: Q1 2026 in Review

Holocene Advisors sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 56,610 shares — an estimated $639K sold.

Holocene Advisors first reported a position in BHVN in Q4 2022 and held it in 13 quarters. The position peaked at $75.1M in Q1 2024. 277 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Holocene Advisors reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
  • Holocene Advisors sold 56,610 Biohaven shares in Q1 2026, an estimated $639K.
  • Holocene Advisors first reported a position in Biohaven in Q4 2022 and held it in 13 quarters.
  • Holocene Advisors's Biohaven position peaked at $75.1M in Q1 2024.
  • 277 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.